A W Hugin
Overview
Explore the profile of A W Hugin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jenne L, Hauser C, Arrighi J, Saurat J, Hugin A
Gene Ther
. 2000 Oct;
7(18):1575-83.
PMID: 11021596
Dendritic cells (DC) are potent antigen-presenting cells (APC). Ongoing preclinical and clinical studies exploit this capacity for the immunotherapy of tumors. We tested vaccinia virus (VV) as a vector to...
2.
3.
Wirth S, van den Broek M, Frossard C, Hugin A, Leblond I, Pircher H, et al.
Cell Immunol
. 2000 Jun;
202(1):13-22.
PMID: 10873302
Effector T cells secreting type 1 and/or type 2 lymphokines (Tc1, Tc0, Tc2) were generated in vitro from CD8(+) T cells of mice with a transgenic TCR recognizing lymphocytic choriomeningitis...
4.
Hugin A, Fossati-Jimack L, Izui S
Cell Immunol
. 2000 Apr;
200(2):76-80.
PMID: 10753498
Murine acquired immunodeficiency syndrome (MAIDS) is characterized by lymphoproliferation, polyclonal B cell activation resulting in the production of autoantibodies, and a progressive immunodeficiency. These are all hallmarks of some autoimmune...
5.
Hauser C, Zipprich F, Leblond I, Wirth S, Hugin A
J Immunol
. 1999 Jun;
163(1):330-6.
PMID: 10384132
Ag-specific CTL can protect against tumors and some viral infections and may be useful for adoptive immunotherapy. Here, we show that purified CD8+ T cells from naive C57BL/6 mice can...
6.
Hugin A, Tang Y
J Virol Methods
. 1999 Mar;
77(2):217-24.
PMID: 10092145
Murine acquired immunodeficiency syndrome is a lymphoproliferative disease with a concurrently developing immunodeficiency. The disease is induced after injection of supernatant of a chronically infected cell line that releases a...
7.
8.
Tang Y, Hugin A, Giese N, Gabriele L, Chattopadhyay S, Fredrickson T, et al.
J Virol
. 1997 Mar;
71(3):1808-13.
PMID: 9032310
CD8+ T cells were previously shown to be important in preventing lymphoproliferation and immunodeficiency following infection of murine AIDS (MAIDS)-resistant mice with the LP-BM5 mixture of murine leukemia viruses. To...
9.
Hugin A, Rudikoff E, Morse 3rd H
J Immunol Methods
. 1995 Oct;
186(1):151-4.
PMID: 7561143
Medium batches, analysed in various spontaneous and mitogen induced proliferation assays, revealed heterogeneity in their growth promoting activity. This can critically affect test results and suggests that culture media can...
10.
Tang Y, Kim W, Holmes K, Hugin A, KENNY J, Chattopadhyay S, et al.
Cell Immunol
. 1995 Oct;
165(1):1-6.
PMID: 7545546
C57BL/6 (B6) mice develop a syndrome of progressive lymphoproliferation and immunodeficiency, murine AIDS (MAIDS), when infected with an etiologic replication-defective virus termed BM5def. Induction of MAIDS requires the presence of...